Hui Xin (YY) Ong
ROSEBERY,NSW
Summary
Dynamic leader with a proven track record at Ab Initio Pharma and Macquarie University, enhancing research capabilities across teams and securing over $4 million in funding. Specializes in inhalation and intranasal drug delivery, demonstrating exceptional project management and collaboration skills. Known for fostering innovation and driving projects from concept to commercialization, significantly advancing respiratory pharmaceutics.
Overview
8
8
years of professional experience
Work History
Chief Scientific Officer and Head of R&D
Ab Initio Pharma
10.2020 - Current
- Spearheaded innovative research initiatives, resulting in numerous patents and publications.
- Collaborated with cross-functional teams to drive product development from R&D concept, GMP manufacture and commercialization.
- Managed budgetary planning for departmental resources to ensure optimal allocation of funds towards high-priority projects.
- Championed data-driven decision making, optimizing resource allocation and project prioritization.
- Developed strategic partnerships with academic institutions and industry leaders, enhancing the organization's research capabilities.
- Optimized lab operations through use of eQMS and e-lab book, regular review of safety protocols, equipment maintenance schedules, and personnel training programs.
- Cultivated company-wide culture of innovation and collaboration.
Senior Research Fellow
Macquarie University
07.2021 - Current
- Won research grants and completed industry studies funded by corporate groups including Insmed (US), Aptar (France), Next Science (Aus), Defence department (Aus).
- Scientific Advisory Board of Tetratherix
- Chair of the Woolcock Institute Research Committee
- Presented research findings at national and international conferences including Respiratory Drug Delivery and Drug Delivery to the Lung, positioning the institution as a leader in the field.
- Graduated 8 PhD students to completion and mentored junior researchers, providing guidance on study design and data analysis techniques for successful project outcomes.
- Managed interdisciplinary teams to maximize collaboration and ensure timely completion of research projects.
- Oversaw studies, documented data, and extrapolated results resulting in publications of over 75 publications in top-ranked pharmaceutical journals
- Secured grant funding totalling to > $4 mil by preparing compelling proposals, leading to increased financial support for research initiatives.
- Regularly reviewed progress reports from team members, adjusting timelines and resources as needed to maintain project momentum.
Lecturer
University Of Sydney
01.2016 - 06.2021
- I was the Director of the Master of Medicine (Pharmaceutical and Medical Device Development- MAMEDICI4PMV) degree, which is a professional vocational degree for those entering or employed within the pharma industry
- I developed and coordinated the degree from the ground up and have worked in partnership with industry to make it a reality.
- The degree was designed to be taught by industry professionals and has an advisory board consisting of small medium enterprise, large corporate industry, industry bodies and the regulatory sector to provide a relevant learning experience for those developing pharmaceutical and MedTech products, from conception through to license and manufacture.
- Increased student interest by incorporating real-world examples into lessons and connecting material to relevant experiences.
- Used variety of learning modalities and support materials to facilitate learning process and accentuate presentations.
- The degree was awarded the Excellence in Education by the Sydney Medical School (2019).
Education
Ph.D. - Pharmaceutics
University of Sydney
Faculty Of Medicine 10.2013
B. Pharm. - Pharmacy
University of Sydney
Faculty Of Pharmacy12.2009
Skills
- In-depth Subject Knowledge in inhalation and intranasal drug delivery
- Effective project management across a wide range of projects
- Critical thinking abilities to problem solve effectively
- Skilled in respiratory pharmaceutics including dry powder, solution, nanoparticle generation, suspension, pMDI and cell culture
- Teamwork and Collaboration across different cross-functional teams
- Decision-Making based on data presented Organization and Time Management ensuring all milestones are met in timely manner and of high quality
- Excellent Communication in both written and verbal to external and internal stakeholders
Accomplishments
- Awarded the 2021 Drug Delivery to the Lung Emerging Scientist Award and the International Society of Aerosol Medicine Young Investigator Award 2023 in recognition of my international reputation as a emerging leader contributing to inhalation medicines.
- Led the establishment of Ab Initio Pharma, a premier CDMO based in Sydney from ground up and have positioned it as a company for the commercialisation of aerosol therapies, and a launchpad for innovators to rapidly translate their product into clinical practice. Ab Initio was listed in the Australia Financial Review as one of the fastest growing start-up companies in Australia.
- Well-rounded experience in industry and academic research, to translate basic research into commercial outcomes that will benefit the healthcare sector and community.
- Published >75 publications, attracted > $ 4 mil in grant funding, hold several patents, and numerous presented at national and international conferences
Affiliations
- Research Leader at the Woolcock Institute of Medical Research
Timeline
Senior Research Fellow
Macquarie University
07.2021 - Current
Chief Scientific Officer and Head of R&D
Ab Initio Pharma
10.2020 - Current
Lecturer
University Of Sydney
01.2016 - 06.2021
Ph.D. - Pharmaceutics
University of Sydney
B. Pharm. - Pharmacy
University of Sydney
Similar Profiles
Sruthy JanardananSruthy Janardanan
Production Engineer & Safety Officer at NextCell Pharma ABProduction Engineer & Safety Officer at NextCell Pharma AB
Patricia ChapelinPatricia Chapelin
Account Executive at Initio Parfums Prives & Parfums De MarlyAccount Executive at Initio Parfums Prives & Parfums De Marly
Joakim WiddasJoakim Widdas
AP/AR Accountant at Max Matthiessen AB (Agigo AB)AP/AR Accountant at Max Matthiessen AB (Agigo AB)